(Q37150734)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18446144 AND SRC:MED&resulttype=core&format=json

6 January 2020

review article

1 reference

title

Primer: first do no harm--when is it appropriate to plan a cancer prevention clinical trial? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18446144 AND SRC:MED&resulttype=core&format=json

6 January 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18446144 AND SRC:MED&resulttype=core&format=json

6 January 2020

author name string

Eva Szabo

series ordinal

1

1 reference

18 August 2017

publication date

29 April 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18446144 AND SRC:MED&resulttype=core&format=json

Nature Clinical Practice Oncology

6 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18446144 AND SRC:MED&resulttype=core&format=json

6 January 2020

volume

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18446144 AND SRC:MED&resulttype=core&format=json

6 January 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18446144 AND SRC:MED&resulttype=core&format=json

6 January 2020

page(s)

348-356

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18446144 AND SRC:MED&resulttype=core&format=json

The utility of genetically altered mouse models for nutrition and cancer chemoprevention research

6 January 2020

cites work

1 reference

A randomized clinical trial evaluating tamoxifen in the treatment of patients with node-negative breast cancer who have estrogen-receptor-positive tumors

21 January 2018

1 reference

SELECT: the selenium and vitamin E cancer prevention trial

21 January 2018

1 reference

A randomized phase IIb trial of anethole dithiolethione in smokers with bronchial dysplasia

21 January 2018

1 reference

Cancer chemoprevention: scientific promise, clinical uncertainty

21 January 2018

1 reference

7 January 2021

Progress in chemoprevention drug development: the promise of molecular biomarkers for prevention of intraepithelial neoplasia and cancer--a plan to move forward

1 reference

7 January 2021

The convergent development of molecular-targeted drugs for cancer treatment and prevention

1 reference

7 January 2021

Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial

1 reference

7 January 2021

The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers

1 reference

7 January 2021

Cancer. Addiction to oncogenes--the Achilles heal of cancer

1 reference

7 January 2021

State-of-the art therapy for gastrointestinal stromal tumors

1 reference

7 January 2021

A phase II trial of imatinib (ST1571) in patients with c-kit expressing relapsed small-cell lung cancer: a CALGB and NCCTG study.

1 reference

7 January 2021

Lack of c-kit exon 11 activating mutations in c-KIT/CD117-positive SCLC tumour specimens

1 reference

7 January 2021

Peroxisome proliferator-activated receptor-gamma is a target of nonsteroidal anti-inflammatory drugs mediating cyclooxygenase-independent inhibition of lung cancer cell growth

1 reference

7 January 2021

How good are rodent models of carcinogenesis in predicting efficacy in humans? A systematic review and meta-analysis of colon chemoprevention in rats, mice and men

1 reference

7 January 2021

The promise of genetically engineered mice for cancer prevention studies

1 reference

7 January 2021

The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis

1 reference

7 January 2021

Celecoxib for the prevention of sporadic colorectal adenomas

1 reference

7 January 2021

Celecoxib for the prevention of colorectal adenomatous polyps

1 reference

7 January 2021

Can dietary beta-carotene materially reduce human cancer rates?

1 reference

7 January 2021

Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease

1 reference

7 January 2021

Retinoid signaling and activator protein-1 expression in ferrets given beta-carotene supplements and exposed to tobacco smoke.

1 reference

7 January 2021

Cyclooxygenase inhibition in cancer prevention and treatment

1 reference

7 January 2021

A randomized trial of aspirin to prevent colorectal adenomas

1 reference

7 January 2021

A randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer

1 reference

7 January 2021

A randomized trial of rofecoxib for the chemoprevention of colorectal adenomas.

1 reference

7 January 2021

Aspirin and the risk of colorectal cancer in relation to the expression of COX-2.

1 reference

7 January 2021

Diet and cancer: the disconnect between epidemiology and randomized clinical trials

1 reference

7 January 2021

Orange juice vs vitamin C: effect on hydrogen peroxide-induced DNA damage in mononuclear blood cells

1 reference

7 January 2021

The Effect of Raloxifene on Risk of Breast Cancer in Postmenopausal Women

1 reference

7 January 2021

Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study

1 reference

7 January 2021

Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional Prevention of Cancer Study Group.

1 reference

7 January 2021

The chemoradiation paradigm in head and neck cancer

1 reference

7 January 2021

Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial

1 reference

7 January 2021

Adverse cardiovascular effects of rofecoxib

1 reference

7 January 2021

Effect of muraglitazar on death and major adverse cardiovascular events in patients with type 2 diabetes mellitus

1 reference

7 January 2021

Effect of Rosiglitazone on the Risk of Myocardial Infarction and Death from Cardiovascular Causes

1 reference

7 January 2021

Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial

1 reference

7 January 2021

Projecting individualized probabilities of developing breast cancer for white females who are being examined annually

1 reference

7 January 2021

Variations in lung cancer risk among smokers.

1 reference

7 January 2021

A risk model for prediction of lung cancer

1 reference

7 January 2021

Oral leukoplakia and malignant transformation. A follow-up study of 257 patients

1 reference

7 January 2021

A randomized phase IIb trial of pulmicort turbuhaler (budesonide) in people with dysplasia of the bronchial epithelium.

1 reference

7 January 2021

Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention

1 reference

7 January 2021

The influence of finasteride on the development of prostate cancer

1 reference

7 January 2021

Identifiers

DOI

10.1038/NCPONC1123

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18446144 AND SRC:MED&resulttype=core&format=json

6 January 2020

1 reference